Zyloprim: Effective Uric Acid Control for Gout Management
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.35 | $63.60 (0%) | 🛒 Add to cart |
| 270 | $0.33 | $95.40 $87.83 (8%) | 🛒 Add to cart |
| 360 | $0.31
Best per pill | $127.21 $111.05 (13%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.41 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $65.12 $53.51 (18%) | 🛒 Add to cart |
| 120 | $0.54 | $86.82 $64.61 (26%) | 🛒 Add to cart |
| 180 | $0.47 | $130.23 $84.80 (35%) | 🛒 Add to cart |
| 270 | $0.43 | $195.35 $115.09 (41%) | 🛒 Add to cart |
| 360 | $0.40
Best per pill | $260.47 $145.38 (44%) | 🛒 Add to cart |
Synonyms
| |||
Zyloprim (allopurinol) is a xanthine oxidase inhibitor prescription medication specifically formulated for the long-term management of hyperuricemia, the underlying cause of gout and certain types of kidney stones. By targeting the enzymatic source of uric acid overproduction, it provides a prophylactic approach to preventing painful gout attacks and the formation of urate crystals. This therapy is a cornerstone in the chronic management of conditions associated with elevated serum urate levels, offering patients a path toward sustained symptomatic control and improved quality of life. Treatment is typically initiated under the supervision of a rheumatologist or primary care physician following a confirmed diagnosis.
Features
- Pharmaceutical active ingredient: Allopurinol
- Available in scored tablet formulations for easy dose splitting (100 mg and 300 mg strengths)
- Mechanism of Action: Potent inhibitor of the enzyme xanthine oxidase
- Reduces the production of uric acid from its metabolic precursors
- Bioequivalent to the reference listed drug
- Requires a prescription from a licensed healthcare provider
Benefits
- Prophylaxis of Gout Attacks: Significantly reduces the frequency and severity of acute, painful gout flares with consistent long-term use.
- Prevents Tophus Formation: Aids in the gradual dissolution of existing urate crystal deposits (tophi) and prevents the development of new ones, protecting joint integrity.
- Reduces Risk of Uric Acid Nephrolithiasis: Lowers the concentration of uric acid in the urine, thereby decreasing the likelihood of forming uric acid kidney stones.
- Manages Hyperuricemia Secondary to Cytotoxic Therapy: Effectively controls elevated uric acid levels that can occur during chemotherapy for malignancies, helping to prevent tumor lysis syndrome.
- Long-Term Disease Modification: Addresses the root metabolic cause of hyperuricemia rather than merely treating acute inflammatory symptoms.
Common use
Zyloprim is primarily indicated for the management of conditions resulting from chronic hyperuricemia. Its most common application is in the prevention of gout attacks and the chronic management of gouty arthritis. It is not used for the immediate relief of an acute gout attack, as initiation of therapy can sometimes precipitate an acute flare. It is also employed to manage hyperuricemia secondary to blood cancers and their treatments, and to prevent the recurrence of uric acid kidney stones. Use is typically lifelong for chronic gout management, contingent on patient tolerance and therapeutic efficacy.
Dosage and direction
Dosage is highly individualized based on the severity of the condition, renal function, and therapeutic response. The goal is to lower and maintain serum uric acid levels below 6 mg/dL.
- Adults (Gout & Hyperuricemia): The recommended starting dose is 100 mg once daily. The dose may be increased by 100 mg weekly until a serum uric acid level of <6 mg/dL is achieved. The average maintenance dose is 200-300 mg daily for mild gout, and 400-600 mg daily for moderate to severe tophaceous gout. Doses exceeding 300 mg per day should be administered in divided doses.
- Dosing in Renal Impairment: Dosage must be adjusted for patients with impaired kidney function. A lower initial dose (e.g., 100 mg every other day or 100 mg daily) is recommended, with slower titration and a lower maximum daily dose, guided by creatinine clearance.
- Administration: Tablets should be taken orally, with a full glass of water, after a meal to minimize potential gastric upset. Consistent daily adherence is critical for long-term success. Patients must maintain adequate hydration (8 glasses of fluid per day minimum).
Precautions
- Initiation of Therapy: Therapy should not be started during an acute gout attack. It is preferable to wait until the acute flare has fully subsided, often with the concomitant use of NSAIDs or colchicine for prophylaxis during the first few months of Zyloprim treatment.
- Renal Function: Serum creatinine levels should be monitored regularly, as dosage adjustments are necessary for patients with renal impairment.
- Hepatic Function: Periodic liver function tests are advised, as rare cases of hepatotoxicity have been reported.
- CBC Monitoring: Periodic complete blood counts are recommended due to rare reports of bone marrow suppression.
- Skin Reactions: Patients must be advised to discontinue the drug immediately and contact their physician at the first sign of a rash, skin peeling, blistering, or mucosal lesions, as these can be signs of a severe hypersensitivity reaction.
Contraindications
Zyloprim is contraindicated in patients with a history of a severe hypersensitivity reaction to allopurinol or any component of the formulation. This includes patients who have previously experienced Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) in association with allopurinol use.
Possible side effect
While many patients tolerate Zyloprim well, side effects can occur. The most common are generally mild and may include:
- Skin rash (maculopapular)
- Nausea, vomiting, or diarrhea
- Drowsiness or dizziness
- Headache
- Changes in liver function tests
More serious, but less common, side effects require immediate medical attention:
- Severe skin reactions (e.g., SJS, TEN, drug rash with eosinophilia and systemic symptoms [DRESS])
- Hepatotoxicity (hepatitis, jaundice)
- Bone marrow depression (leukopenia, thrombocytopenia, agranulocytosis)
- Eosinophilia
- Vasculitis
Drug interaction
Zyloprim has several clinically significant drug interactions:
- Azathioprine & 6-Mercaptopurine: Allopurinol inhibits the metabolism of these drugs, drastically increasing their toxicity. The dose of azathioprine or mercaptopurine must be reduced to ¼ to ⅓ of the usual dose when co-administered with Zyloprim.
- Warfarin: Allopurinol may potentiate the anticoagulant effect of warfarin, increasing the risk of bleeding. INR should be monitored closely.
- ACE Inhibitors (e.g., lisinopril): Concomitant use may increase the risk of hypersensitivity reactions, including Stevens-Johnson syndrome.
- Diuretics (especially Thiazides): May increase the risk of allopurinol-induced hypersensitivity reactions.
- Ampicillin/Amoxicillin: Increased incidence of skin rash has been observed with concurrent use.
- Theophylline: Allopurinol may increase serum theophylline levels.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Patients should not take a double dose to make up for a missed one. Maintaining a consistent daily schedule is important for effective uric acid control.
Overdose
Symptoms of overdose may include severe nausea, vomiting, diarrhea, and dizziness. In cases of significant overdose, acute renal failure and hepatotoxicity have been reported. There is no specific antidote for allopurinol overdose. Management involves gastric lavage if ingestion was recent, vigorous hydration to promote excretion, and supportive symptomatic treatment. Hemodialysis may be effective in removing allopurinol and its primary metabolite, oxypurinol, from the bloodstream.
Storage
Store Zyloprim tablets at room temperature (20°-25°C or 68°-77°F), in a tightly closed container. Protect from light, moisture, and excessive heat. Keep all medications out of the reach of children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard expired or no-longer-needed medication through a medicine take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for the professional judgment of a qualified healthcare provider in diagnosing and treating patients. The information does not cover all possible uses, directions, precautions, drug interactions, or adverse effects. The absence of a warning for a given drug or combination does not imply that the drug or combination is safe, effective, or appropriate for any given patient. Patients must consult with a physician or other healthcare professional for medical advice before starting, stopping, or changing any part of their healthcare plan or treatment.
Reviews
- “After suffering from debilitating gout attacks for years, Zyloprim has given me my life back. It took a few months to fully take effect, but I haven’t had a major flare in over two years. The difference is night and day.” – Mark T., 58
- “As an oncologist, I rely on allopurinol to safely manage uric acid levels in my patients undergoing chemotherapy. It is a critical prophylactic tool for preventing tumor lysis syndrome, a serious complication.” – Dr. Eleanor R.
- “The initial few weeks were rough with a minor flare, but my doctor warned me this might happen. Stuck with it with colchicine cover and now my uric acid levels are perfectly controlled. No side effects to report.” – James L., 45
- “Important medication that works well, but requires patience and strict adherence. Regular blood tests are a must to ensure everything is on track.” – Sarah K., 62

